Pfizer Inc. (PFE)

Pfizer Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	-	2,853	416	1,944	1,786	1,121
Short-Term Investments	-	9,837	22,316	29,125	10,437	8,525
Trading Asset Securities	-	-	-	4	18	53
Cash & Short-Term Investments	7,100	12,690	22,732	31,073	12,241	9,699
Cash Growth	-83.93%	-44.18%	-26.84%	153.84%	26.21%	-48.76%
Accounts Receivable	-	11,177	10,952	11,479	7,913	6,772
Other Receivables	-	3,978	3,577	4,266	3,264	2,736
Receivables	-	15,155	14,529	15,745	11,177	9,508
Inventory	-	10,189	8,981	9,059	8,020	7,068
Other Current Assets	-	5,299	5,017	3,816	3,629	6,528
Total Current Assets	-	43,333	51,259	59,693	35,067	32,803
Property, Plant & Equipment	-	21,864	19,276	17,721	15,131	14,258
Long-Term Investments	-	15,382	14,926	21,348	20,379	20,413
Goodwill	-	67,783	51,375	49,208	49,556	48,202
Other Intangible Assets	-	64,900	43,370	25,146	28,337	33,936
Long-Term Deferred Tax Assets	-	1,800	4,800	1,600	900	700
Other Long-Term Assets	-	11,439	12,199	6,760	4,859	17,282
Total Assets	-	226,501	197,205	181,476	154,229	167,594
Accounts Payable	-	6,710	6,809	5,578	4,283	3,887
Accrued Expenses	-	9,224	8,316	7,671	6,498	5,281
Short-Term Debt	-	8,096	385	605	701	14,733
Current Portion of Long-Term Debt	-	2,270	2,570	1,636	2,002	1,462
Current Portion of Leases	-	527	620	449	320	269
Current Income Taxes Payable	-	2,349	1,587	1,266	1,049	980
Current Unearned Revenue	-	2,700	2,520	3,067	2,070	-
Other Current Liabilities	-	15,918	19,331	22,399	8,997	10,692
Total Current Liabilities	-	47,794	42,138	42,671	25,920	37,304
Long-Term Debt	-	61,813	33,205	36,195	37,133	35,955
Long-Term Leases	-	2,626	2,597	2,510	1,108	1,030
Long-Term Deferred Tax Liabilities	-	640	1,023	349	4,063	5,652
Other Long-Term Liabilities	-	22,173	20,075	18,564	17,121	17,990
Total Liabilities	-	137,213	101,288	104,013	90,756	104,148
Common Stock	-	478	476	473	470	468
Additional Paid-In Capital	-	92,631	91,802	90,591	88,674	87,428
Retained Earnings	-	118,353	125,656	103,394	90,392	97,670
Treasury Stock	-	-114,487	-113,969	-111,361	-110,988	-110,801
Comprehensive Income & Other	-	-7,961	-8,304	-5,896	-5,310	-11,639
Total Common Equity	87,700	89,014	95,661	77,201	63,238	63,126
Minority Interest	-	274	256	262	235	303
Shareholders' Equity	87,975	89,288	95,917	77,463	63,473	63,446
Total Liabilities & Equity	-	226,501	197,205	181,476	154,229	167,594
Total Debt	69,858	75,332	39,377	41,395	41,264	53,449
Net Cash (Debt)	-62,758	-62,642	-16,645	-10,322	-29,023	-43,750
Net Cash Per Share	-11.01	-10.97	-2.90	-1.81	-5.15	-7.71
Filing Date Shares Outstanding	5,667	5,647	5,619	5,623	5,578	5,548
Total Common Shares Outstanding	5,667	5,646	5,616	5,620	5,567	5,534
Working Capital	-	-4,461	9,121	17,022	9,147	-4,501
Book Value Per Share	15.48	15.77	17.03	13.74	11.36	11.41
Tangible Book Value	-41,985	-43,669	916	2,847	-14,655	-19,012
Tangible Book Value Per Share	-7.41	-7.73	0.16	0.51	-2.63	-3.44
Land	-	353	368	423	443	495
Buildings	-	9,046	8,832	9,001	8,998	9,181
Machinery	-	19,661	17,373	16,710	15,484	15,489
Construction In Progress	-	5,925	4,875	3,822	3,481	2,794

Source: S&P Capital IQ. Standard template. Financial Sources.